(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COMPUGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

COMPUGEN

ST13

US500000077562462

Class

42, 45

Filing

77562462

Registration

3660278

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

03/20/2019

Trademark type

Combined

Nice classes

42, 45

Filing date

09/04/2008

Registration date

07/28/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/20/2019

Last transaction

03/20/2019

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

09/08/2004

First use in commerce

09/08/2004

Drawing code

3

Owner type

03

Owner location

Tel Aviv, IL

Examiner

FOSDICK, GEOFFREY

Law office

M20

Current location

TMO LAW OFFICE 111

Mark description

The mark consists of the word "Compugen" with a stylized double helix DNA structure.

Holders and representatives

Holders

Compugen Ltd.

Representatives

Kevin D. McCarthy Roach Brown McCarthy & Gruber, P.C.

Technical classification

Nice Classes

Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceuticaltherapeutic and diagnostic drug discovery services; testinganalysis and evaluation of the pharmaceuticaltherapeutic and diagnostic research and development services of others for the purpose of certification; conducting of pharmacogenetic feasibility studies and scientific research for others; medical research in the nature of computerized genetic analysis of DNAnucleic acids and other biological matter analysis; medical research in the nature of proteome analysis for therapeutic and diagnostic candidate discovery; development of new technology for others in the field of drug discoverydiagnostic discovery and genomics

Class 45

Licensing of intellectual property arising from scientific research and development for others

Publications

History of USPTO decisions and trademark events.

27 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/20/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/20/2019

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

03/20/2019

8PRT

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

03/20/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/20/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

02/19/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/28/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/25/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/25/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/25/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/25/2014

E815

TEAS SECTION 8 & 15 RECEIVED

08/11/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

07/28/2009

PUBO

PUBLISHED FOR OPPOSITION

05/12/2009

NPUB

NOTICE OF PUBLICATION

04/22/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/03/2009

ALIE

ASSIGNED TO LIE

04/01/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/01/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/31/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/31/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/31/2009

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/08/2008

GNRT

NON-FINAL ACTION E-MAILED

12/08/2008

CNRT

NON-FINAL ACTION WRITTEN

12/08/2008

DOCK

ASSIGNED TO EXAMINER

12/08/2008

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

09/09/2008

NWAP

NEW APPLICATION ENTERED

09/08/2008

Continuous trademark protection

Get notified about every new filing that threatens COMPUGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.